Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP/TGFβ1 after myocardial infarction.
Laura Alonso-HerranzÁlvaro Sahún-EspañolAna ParedesPilar GonzaloPolyxeni GkontraVanessa NúñezCristina ClementeMarta CedenillaMaría Villalba-OreroJavier InserteDavid García-DoradoAlicia G ArroyoMercedes RicotePublished in: eLife (2020)
Macrophages (Mφs) produce factors that participate in cardiac repair and remodeling after myocardial infarction (MI); however, how these factors crosstalk with other cell types mediating repair is not fully understood. Here we demonstrated that cardiac Mφs increased the expression of Mmp14 (MT1-MMP) 7 days post-MI. We selectively inactivated the Mmp14 gene in Mφs using a genetic strategy (Mmp14f/f:Lyz2-Cre). This conditional KO (MAC-Mmp14 KO) resulted in attenuated post-MI cardiac dysfunction, reduced fibrosis, and preserved cardiac capillary network. Mechanistically, we showed that MT1-MMP activates latent TGFβ1 in Mφs, leading to paracrine SMAD2-mediated signaling in endothelial cells (ECs) and endothelial-to-mesenchymal transition (EndMT). Post-MI MAC-Mmp14 KO hearts contained fewer cells undergoing EndMT than their wild-type counterparts, and Mmp14-deficient Mφs showed a reduced ability to induce EndMT in co-cultures with ECs. Our results indicate the contribution of EndMT to cardiac fibrosis and adverse remodeling post-MI and identify Mφ MT1-MMP as a key regulator of this process.
Keyphrases
- cell migration
- endothelial cells
- left ventricular
- stem cells
- transforming growth factor
- bone marrow
- gene expression
- emergency department
- genome wide
- single cell
- epithelial mesenchymal transition
- dna methylation
- mesenchymal stem cells
- induced apoptosis
- atrial fibrillation
- copy number
- binding protein
- transcription factor
- drug induced
- adverse drug